School of Medicine
Showing 51-100 of 111 Results
-
Joanna E. Liliental, PhD
Director, TRAM, M-TRAM, TASC, Med/TRAM
Current Role at StanfordExecutive Director, Master's in TRAM (M-TRAM)
https://med.stanford.edu/tram/masters-program.html
Director, Translational Applications Service Center (TASC)
http://tasc.stanford.edu
Associate Director, Translational Research and Applied Medicine (TRAM) Program
http://tram.stanford.edu
Senior Research Scientist, Stanford School of Medicine
Instructor of University Courses: MED221,MED121, MED212A
Member, Stanford Cancer Institute -
Xin Liu
Basic Life Science Research Scientist, Genetics
BioXin Liu is a postdoctoral Research Scientist in the Department of Genetics at Stanford University. Xin holds a PhD in Chemistry from the University of Michigan, Ann Arbor. Her basic research interests include RNA and protein biochemistry, enzymology, cancer immunology, and autoimmune disease. She has published papers in several prestigious journals in the field of biochemistry, including Nature Communications, Journal of American Chemical Society, and Nucleic Acids Research. The highlight of her multidisciplinary research includes the development of high-throughput enzymatic methods to discover anti-microbial agents and to reveal mechanisms behind human mitochondrial diseases, as well as innovative applications of genome engineering and machine-learning to decode principles of RNA editing in human cells. Her current research focuses on the mechanistic study of innate immune pathways.
-
Kathryn Melsop
Director, Finance & Facility Operations, Stanford Laboratory for Cell and Gene Medicine
Current Role at StanfordDirector, Finance and Facility Operations at the Laboratory for Cell & Gene Medicine.
-
Antonio Meola, MD, PhD
BioAntonio Meola M.D. Ph.D graduated Summa cum Laude and Research Honors at the University of Pisa, Italy, in 2008, and completed his residency training in Neurosurgery at the same Institution in July 2015. Dr Meola attended a Ph.D. program at the University of Florence, Italy, where he discussed a doctoral thesis entitled "A New Head-Mounted Display-based Augmented Reality System in Neurosurgical Oncology: a study on phantom".
Since 2/2014 to 1/2015 Dr Meola completed a Research Fellowship in Neurosurgical anatomy at the University of Pittsburgh Medical Center (UPMC), under the Direction of Dr. Juan C. Fernandez-Miranda. The main focus of his research was the surgical neuroanatomy of the white matter tracts of the human brain.
Since 7/2015 to 6/2016 Dr Meola served as Clinical Fellow in Image-Guided Neurosurgery at the Brigham and Women's Hospital, Harvard Medical School, in Boston, MA (Director: Dr. Alexandra J. Golby M.D.). During the fellowship, he focused on the clinical application and integration of advanced imaging techniques, including intraoperative-MRI, intraoperative US, functional MRI, tractography.
Since 7/2016 to 6/2017 Dr Meola completed a Neurosurgical Oncology Fellowship at the Cleveland Clinic in Cleveland, OH, devoting his efforts to minimally-invasive neurosurgical techniques, such as Laser interstitial Thermal Therapy (LITT) and stereotactic radiosurgery (Gamma Knife), as well as to awake neurosurgery.
Starting 7/2017, Dr Meola joined the Department of Neurosurgery at Stanford. Dr. Meola mainly focuses on conventional and innovative treatments for brain and skull base tumors, including both surgery and stereotactic radiosurgery (CyberKnife). -
Pardis Miri
Postdoctoral Scholar, Genetics
BioPardis Miri, PhD, is a postdoctoral fellow at Stanford University where she is focused on building technology to facilitate mental well being. With a PhD in computer science and years of training in area of affective science (under the supervision of Professor James J. Gross), Pardis has assembled a unique team (see http://wehab.stanford.edu) to not only run clinical studies to evaluate their efficacy in changing emotion, mood, and stress but also build product-ready technology.
Pardis is the principal investigator of a large multi-disciplinary project (FAR) to design, build, and evaluate a wearable system tailored to the needs of children with emotion dysregulation, especially children diagnosed with autism spectrum disorder. FAR aims to empower them to manage their problem behaviors in a more adaptive way. The FAR project involves collaborations between the departments of Computer Science, Psychology, Mechanical Engineering, and the School of Medicine at Stanford University.
Pardis is being advised by Professors Micheal Snyder, Professor Keith Marzullo at the University of Maryland iSchool, whose research is on distributed systems, and by Professor James Gross, whose research underlies much of what we now know about emotion regulation. She is also working with Professor Antonio Hardan of the Stanford School of Medicine, whose research is on children with Autism Spectrum Disorder. -
Dhriti Nagar
Postdoctoral Scholar, Neonatal and Developmental Medicine
BioPremature birth is a leading cause of developmental and neuropsychiatric disorders in children. One of the factors causing these defects is lowered levels of available oxygen (hypoxia) in the newborn due to immature lungs. My research focuses on understanding the cellular and molecular mechanisms underlying hypoxia-induced developmental disorders of the nervous system due to preterm birth.
-
Michitaka Nakano
Basic Life Research Scientist, Medicine - Med/Hematology
BioI am a MD/PhD postdoctoral fellow and medical oncologist with a long-standing interest in translational cancer research. My long-term goal is to be a lab-based physician-scientist and independent academic researcher, translating basic cancer research, and mentoring next-generation scientists. My thesis work in Japan focused on cancer stem cell equilibrium by uniquely applying organoid culture as a method to elucidate cancer stem cell dynamics, which was awarded in Japanese Cancer Association. Along with the development of the field represented by success in T cell checkpoint, my interest gradually shifted to immune oncology while I examined numerous numbers of cancer patients as a medical oncology fellow. My postdoctoral fellowship at Calvin Kuo Lab in Stanford (2019-present) focuses on tumor immune microenvironment. Kuo lab developed a unique 3D air-liquid interface (ALI) organoid system that cultures tumors while preserving their endogenous infiltrating immune cells (T,B ,NK, Myeloid cells). My postdoctoral work will prove the significance of organoids as a translational tool to discover tumor-immune interaction by novel checkpoint inhibitors for immune cells, which can be broadly applicable to basic cancer biology, precision medicine, therapeutics validation and biomarker discovery.
-
Kouta Niizuma
Basic Life Research Scientist, Stem Cell Bio Regenerative Med Institute
BioI am a Research Scientist in Prof. Hiromitsu Nakauchi's laboratory at Stanford University. I obtained my PhD in Immunology from the University of Tsukuba, Japan. During my doctoral studies in Prof. Akira Shibuya's laboratory, I focused on the characterization of cell surface receptors expressed on immune cells. I successfully cloned a novel human immunoglobulin-like receptor, CD300H, and established a specific monoclonal antibody. My research demonstrated that CD300H is expressed on a subset of human monocytes and dendritic cells and plays a crucial role in enhancing inflammation by promoting the production of inflammatory cytokines and chemokines.
During my PhD, I also studied as a visiting scholar in Prof. Lewis L. Lanier's laboratory at UCSF, where I investigated the role of the activating receptor NKG2D on NK cells in viral immunity.
Since May 2018, I have been a member of the Nakauchi lab. My current research focuses on the development of new immunotherapies using myeloid cells derived from iPS cells, the generation of monoclonal antibodies, and hematopoietic stem cell biology. -
Margaret Claire Nikolov
Senior Manager of Quantitative Analysis, Clinical Excellence Research Center (CERC) Operations
BioDr. Meg Nikolov joined CERC in July 2022 as Senior Manager of Quantitative Analysis. Prior to CERC, Meg led the Technical Consulting and Advanced Analytics team, National Market Research at Kaiser Permanente, where her work focused on access to care and on telehealth during the COVID-19 pandemic. Prior to relocating to the West Coast, Meg was Assistant Professor in the Math Department at the United States Naval Academy. At the Naval Academy, Meg coordinated and taught the statistics and probability courses, co-taught the capstone research course in quantitative economics, advised student research projects, and collaborated with faculty on interdisciplinary research. Meg continues to collaborate on research exploring gender and racial bias in professional performance evaluations. Meg received her Bachelor of Science in Statistics and Biometry from Cornell University and her PhD in Biostatistics from Harvard T.H. Chan School of Public Health.
-
Danielle Osburg
Administrative Coordinator, Stanford Laboratory for Cell and Gene Medicine
Current Role at StanfordAt the Laboratory for Cell and Gene Medicine (LCGM), I provide administrative and operational support:
- Develop, lead and engage stakeholders in process improvement procedures and initiatives that further promote the lab culture, vision and mission.
- Implement and liaison on HR functions including recruitment, hiring, onboarding and orienting, transitions, and separations.
- Construct and ensure unit policies align with University, Department and Division initiatives, policies and guidelines.
- Manage and create communication platforms and content, sharing lab and campus wide initiatives and events; health and wellness, development offerings, affinity groups, and DEIJ.
- Generate, build and implement innovative organization systems and solutions for data management and reporting.
- Perform finance and travel transactions; STAP, P-Card, T-Card, Expense Reporting, and Procurement.
- Promote a positive culture, experience and development through the creation and coordination of in-lab training opportunities on a wide range of subjects; e.g., Wellness, Communication, Psychological Safety, Interviewing Skills -
Sean Paul Spencer, MD,PhD
Instructor, Medicine - Gastroenterology & Hepatology
BioSean Spencer, MD,PhD is a Gastroenterologist and Physician Scientist at Stanford University working with Justin Sonennburg,PhD to uncover the role of dietary intake on the gut microbiome and mucosal immune system. Sean obtained his medical degree University of Pennsylvania, earning his PhD studying nutritional immunology with Yasmine Belkaid,PhD at the National Institutes of Health (NIH), after which he moved to Boston for residency training at Massachusetts General Hospital and completed his Gastroenterology training at Stanford University. Sean’s career goal is to study mechanisms by which dietary intake influences our microbiome and immune system to better understand and treat gastrointestinal disease.
-
Girija Vasudevan
PDM Senior Manufacturing Specialist, Stanford Laboratory for Cell and Gene Medicine
Current Role at StanfordGirija is a Process Development and Manufacturing Specialist to work on cell and gene therapy applications for rare immunological diseases and cancers, which involves manufacturing clinical-grade products for Stem cell and T-cell therapy.
-
Yonatan Winetraub
Instructor, Structural Biology
Current Research and Scholarly InterestsMy interests span non-invasive imaging for early cancer diagnosis and space exploration.
I'm focusing on utilizing Optical Coherence Tomography (OCT) and machine learning to create virtual histology tools to image cancer non invasively at a single cell resolution, allowing physicians to skip biopsy (read more about the research). Prior to my PhD at Stanford, I co-founded SpaceIL, a non-profit organization that launched the first private interplanetary robotic mission to the Moon launched 2019.
